We are live on ! Find out more
ZBH icon

Zimmer Biomet

1,012 hedge funds and large institutions have $21B invested in Zimmer Biomet in 2025 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 303 increasing their positions, 390 reducing their positions, and 100 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more call options, than puts

Call options by funds: $69.9M | Put options by funds: $34.6M

33% more funds holding in top 10

Funds holding in top 10: 9 → 12 (+3)

24% more capital inflows, than outflows

Capital inflows: $1.52B | Capital outflows: $1.22B

1.34% more ownership

Funds ownership: 91.81% → 93.16% (+1.3%)

2% less funds holding

Funds holding: 1,037 → 1,012 (-25)

12% less first-time investments, than exits

New positions opened: 88 | Existing positions closed: 100

22% less repeat investments, than reductions

Existing positions increased: 303 | Existing positions reduced: 390

Holders
1,012
Holders Change
-25
Holders Change %
-2.41%
% of All Funds
13.51%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.16%
New
88
Increased
303
Reduced
390
Closed
100
Calls
$69.9M
Puts
$34.6M
Net Calls
+$35.2M
Net Calls Change
+$56.8M

ZBH Hedge Fund Activity: Q1 2025 in Review

1,012 of the 7,492 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2025, worth a combined $21B — up 8.8% from $19.3B a quarter earlier.

Sellers outnumbered buyers: 100 funds closed out of ZBH and 88 opened new positions — a net loss of 12 holders — while 390 trimmed existing stakes and 303 added.

The largest buyer was Ameriprise, adding an estimated $343M. The largest seller was Fidelity Investments, cutting an estimated $132M.

  • 1,012 institutional investors held Zimmer Biomet (ZBH) as of Q1 2025, down from 1,037 in Q4 2024.
  • Funds reported $21B of Zimmer Biomet stock for Q1 2025, up 8.8% quarter-over-quarter.
  • 88 funds opened new Zimmer Biomet positions in Q1 2025 and 100 closed out, a net change of -12 holders.
  • The largest Zimmer Biomet buyer in Q1 2025 was Ameriprise, an estimated $343M added.
  • The largest Zimmer Biomet seller in Q1 2025 was Fidelity Investments, an estimated $132M sold.

Based on aggregated 13F filings for Q1 2025.